Literature DB >> 29398444

Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine.

Kang Jin1, Kathy Hiu Laam Po2, Wang Yeuk Kong1, Chung Hei Lo1, Chun Wah Lo1, Ho Yin Lam1, Amaya Sirinimal1, Jonathan Avraham Reuven1, Sheng Chen3, Xuechen Li4.   

Abstract

Teixobactin is a structurally and mechanistically novel antimicrobial peptide with potent activities against Gram-positive pathogens. It contains l-allo-enduracididine (End) residue which is not readily accessible. In this report, we have used convergent Ser Ligation as the key step to prepare a series of teixobactin analogues with End being substituted with its non-isostere moieties. Among these analogues, compounds T16, T27 and T29 exhibited the best antimicrobial activities against different Gram-positive bacteria with MICs ranging from 0.25 to 1.0 µM. Structure-activity relationship is also established for further development of more promising teixobactin analogues.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SAR study; Ser ligation; Teixobactin analogues

Mesh:

Substances:

Year:  2018        PMID: 29398444     DOI: 10.1016/j.bmc.2018.01.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

Review 1.  Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.

Authors:  Yasmeen Abouelhassan; Aaron T Garrison; Hongfen Yang; Alejandra Chávez-Riveros; Gena M Burch; Robert W Huigens
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

2.  Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.

Authors:  Ragi Jadimurthy; Shilpa Borehalli Mayegowda; S Chandra Nayak; Chakrabhavi Dhananjaya Mohan; Kanchugarakoppal S Rangappa
Journal:  Biotechnol Rep (Amst)       Date:  2022-04-04

3.  De Novo Resistance to Arg10-Teixobactin Occurs Slowly and Is Costly.

Authors:  Daniel G Lloyd; Benjamin J Schofield; Matthew R Goddard; Edward J Taylor
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.

Authors:  Maytham Hussein; John A Karas; Elena K Schneider-Futschik; Fan Chen; James Swarbrick; Olivia K A Paulin; Daniel Hoyer; Mark Baker; Yan Zhu; Jian Li; Tony Velkov
Journal:  mSystems       Date:  2020-05-26       Impact factor: 6.496

5.  Probing key elements of teixobactin-lipid II interactions in membranes.

Authors:  Po-Chao Wen; Juan M Vanegas; Susan B Rempe; Emad Tajkhorshid
Journal:  Chem Sci       Date:  2018-07-20       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.